Filtered By:
Drug: Rocephin
Vaccination: Pneomococcal Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 49 results found since Jan 2013.
Serotypes and antimicrobial resistance of < em > Streptococcus pneumoniae < /em > in children under 5 years of age pre- and post-pneumococcal conjugate vaccine introduction in Paraguay
Conclusion. A change in the circulating serotypes and antimicrobial resistance to certain antibiotics was observed. Non-vaccine serotype circulation and multidrug resistance may compromise the success of the conjugate vaccines.PMID:37289483 | DOI:10.1099/jmm.0.001700
Source: Journal of Medical Microbiology - June 8, 2023 Category: Microbiology Authors: Mar ía Eugenia León Margarita Samudio An íbal Kawabata Minako Nagai Liliana Rojas Noem í Zárate Juan Irala Myrian Leguizam ón Gloria G ómez Juana Ortellado Raquel Blasco Rossana Franco Gustavo Chamorro Source Type: research
Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil
CONCLUSIONS: Long-term universal childhood use of PCV10 has nearly eliminated carriage with PCV10 serotypes, but the high frequency of MDR isolates, especially associated with serotype 6C/D, remains a concern. Replacing PCV10 with PCV13 should reduce the proportion of ERY-R isolates and PNSP by at least 14% and 18%, respectively.PMID:37061371 | DOI:10.1016/j.vaccine.2023.04.023
Source: Vaccine - April 15, 2023 Category: Allergy & Immunology Authors: Let ícia B D P Fortuna Filipe M Miranda Isa M F Antunes Amanda B Silva Amanda S Cabral Ítalo M Dolores Nayara T Cardoso-Marques L úcia M Teixeira Felipe P G Neves Source Type: research
Microbiological and clinical characteristics of Streptococcus pneumoniae serotype 3 infection and risk factors for severe outcome: A multicenter observational study
CONCLUSIONS: Serotype 3 infection showed a high mortality rate, especially in patients with older ages and comorbidities. Although the incidence rates decreased during the COVID-19 pandemic, serotype 3 remained as an important cause of infection after the implementation of PCV13. Developing a more effective vaccine against serotype 3 and monitoring the antimicrobial-resistant sequence types are necessary.PMID:36774315 | DOI:10.1016/j.jmii.2023.01.013
Source: Journal of Microbiology, Immunology, and Infection - February 11, 2023 Category: Microbiology Authors: Merve Arslan Aydin Rajendra Prasad Janapatla Chyi-Liang Chen Hsin-Chieh Li Lin-Hui Su Cheng-Hsun Chiu Source Type: research
Antimicrobial susceptibility and serotype replacement of Streptococcus pneumoniae in children before and after PCV13 introduction in Taiwan
CONCLUSION: PCV13 was considerably effective in reducing the incidence of IPD in children; however, the prevalence of serotypes 15 A and 23 A increased. The increase in antimicrobial non-susceptibility caused by non-vaccine serotypes must be continuously monitored.PMID:36127232 | DOI:10.1016/j.jmii.2022.08.018
Source: Journal of Microbiology, Immunology, and Infection - September 20, 2022 Category: Microbiology Authors: Hsiang Huang Chien-Yu Lin Nan-Chang Chiu Daniel Tsung-Ning Huang Ching-Ying Huang Hsin Chi Source Type: research
